These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3926568)

  • 1. Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy.
    Bergenstal RM; Dupre J; Lawson PM; Rizza RA; Rubenstein AH
    Diabetes; 1985 Aug; 34 Suppl 3():31-6. PubMed ID: 3926568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII.
    Lawson P; Home PD; Bergenstal R
    Diabetes; 1985 Aug; 34 Suppl 3():27-30. PubMed ID: 3894126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of continuous subcutaneous insulin infusion: evidence that a rise and fall of portal vein insulin concentration with each major meal facilitates post-absorptive glycemic control.
    Rodger NW; Behme MT; Dupre J; Chamberlain MJ
    Clin Invest Med; 1988 Jun; 11(3):167-86. PubMed ID: 3042215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion.
    Tamborlane WV; Champion MC; Rizza RA; Service FJ; Bergenstal RM
    Diabetes; 1985 Aug; 34 Suppl 3():22-6. PubMed ID: 3894125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
    Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
    Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations.
    Rodger NW; Dupre J; Canny CL; Brown WF
    Diabetes Care; 1985; 8(5):447-55. PubMed ID: 3902423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
    Kobayashi T; Sawano S; Itoh T; Kosaka K
    Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S69-78. PubMed ID: 1794269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients.
    Schiffrin A; Belmonte M
    Diabetes Care; 1981; 4(6):595-600. PubMed ID: 6751734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of continuous subcutaneous insulin infusion on endogenous insulin secretion in type I diabetes.
    Pietri A; Alford M; Raskin P
    Diabetes Care; 1982; 5(3):330-3. PubMed ID: 6756842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII.
    Simonson DC; Tamborlane WV; Sherwin RS; Smith JD; DeFronzo RA
    Diabetes; 1985 Aug; 34 Suppl 3():80-6. PubMed ID: 3894130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII.
    Home PD; Capaldo B; Burrin JM; Worth R; Alberti KG
    Diabetes Care; 1982; 5(5):466-71. PubMed ID: 6765222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
    Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB
    Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.
    Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM
    Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma glucose and plasma free insulin during CSII and intensified conventional insulin therapy.
    Buysschaert M; Marchand E; Ketelslegers JM; Lambert AE
    Diabetes Care; 1983; 6(1):1-5. PubMed ID: 6341010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
    Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
    Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal-rate intravenous insulin infusion compared to conventional insulin treatment in patients with type II diabetes. A prospective crossover trial.
    Blackshear PJ; Roussell AM; Cohen AM; Nathan DM
    Diabetes Care; 1989; 12(7):455-63. PubMed ID: 2667926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes.
    Park S; Choi SB
    Am J Clin Nutr; 2002 Apr; 75(4):728-33. PubMed ID: 11916760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.